What is she best known for?
The fields of study she is best known for:
Cancer research, Leukemia, Myeloid leukemia, Molecular biology and Genetics are her primary areas of study.
The concepts of her Cancer research study are interwoven with issues in Haematopoiesis, Stem cell, microRNA, Lymphoma and Myeloid-Lymphoid Leukemia Protein.
The Leukemia study combines topics in areas such as Myeloid and Pathology.
Her study in Myeloid leukemia is interdisciplinary in nature, drawing from both Progenitor cell, Chromosome 7, Genetic testing and Gene expression profiling.
Her Molecular biology study combines topics in areas such as Fluorescence in situ hybridization, Prostate, Proto-oncogene tyrosine-protein kinase Src and Cell cycle checkpoint.
Her Acute leukemia research is multidisciplinary, incorporating perspectives in Myeloproliferative neoplasm, Acute erythroid leukemia, Atypical chronic myeloid leukemia and Intensive care medicine.
Her most cited work include:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (3662 citations)
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
- Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2799 citations)
What are the main themes of her work throughout her whole career to date?
Michelle M. Le Beau mainly focuses on Cancer research, Genetics, Molecular biology, Leukemia and Myeloid leukemia.
Her study on Cancer research also encompasses disciplines like
- Haematopoiesis and related Bone marrow,
- microRNA and related Ectopic expression.
As a part of the same scientific family, Michelle M. Le Beau mostly works in the field of Molecular biology, focusing on Fluorescence in situ hybridization and, on occasion, Contig.
Her Leukemia research integrates issues from Myeloid, Trisomy and Chromosomal translocation.
Her Myeloid leukemia course of study focuses on Oncology and Disease.
She specializes in Immunology, namely Acute leukemia.
She most often published in these fields:
- Cancer research (32.34%)
- Genetics (29.04%)
- Molecular biology (30.36%)
What were the highlights of her more recent work (between 2012-2020)?
- Cancer research (32.34%)
- Myeloid (24.42%)
- Myeloid leukemia (25.74%)
In recent papers she was focusing on the following fields of study:
Michelle M. Le Beau focuses on Cancer research, Myeloid, Myeloid leukemia, Leukemia and Immunology.
Her Cancer research research is multidisciplinary, incorporating elements of Haematopoiesis, Carcinogenesis, microRNA, Regulation of gene expression and Bone marrow.
Her studies in Myeloid leukemia integrate themes in fields like SOX4, Molecular biology, NPM1, Promyelocytic leukemia protein and RUNX1T1.
Leukemia is a subfield of Internal medicine that Michelle M. Le Beau explores.
Her biological study spans a wide range of topics, including Cancer, Anemia, Overall survival, Prognostic classification and Risk stratification.
Her Myelodysplastic syndromes study deals with Intensive care medicine intersecting with Acute leukemia, Myeloproliferative neoplasm, Acute erythroid leukemia and Atypical chronic myeloid leukemia.
Between 2012 and 2020, her most popular works were:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (3662 citations)
- Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2799 citations)
- Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells (362 citations)
In her most recent research, the most cited papers focused on:
Her primary areas of study are Myeloid leukemia, Leukemia, Immunology, Cancer research and Myeloid.
Her Myeloid leukemia study incorporates themes from Mutation, Haploinsufficiency, International working group and Gerontology.
The various areas that Michelle M. Le Beau examines in her Leukemia study include Molecular biology, Cancer, Bone marrow and Downregulation and upregulation.
Her Immunology study integrates concerns from other disciplines, such as Internal medicine and Oncology.
Her studies in Cancer research integrate themes in fields like Insertional mutagenesis, Haematopoiesis, Carcinogenesis, microRNA and Locus.
The various areas that Michelle M. Le Beau examines in her Myelodysplastic syndromes study include Myeloid Neoplasm, Myeloproliferative neoplasm, Intensive care medicine and Acute leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
